{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:34:26Z","timestamp":1791041666688,"version":"4.1.0"},"reference-count":36,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,6,25]]},"DOI":"10.1253\/circj.cj-24-1020","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T22:06:32Z","timestamp":1746914792000},"page":"912-920","source":"Crossref","is-referenced-by-count":11,"title":["Contemporary Guideline-Directed Medical Therapy and Outpatient Worsening Heart Failure Events in Hospitalized Patients With Heart Failure\u3000\u2015 Preliminary Observational Study on Utilizing Predischarge Period for Optimizing Medications in Hospitalized Patients With Heart Failure (PRE-UPFRONT-HF) \u2015"],"prefix":"10.1253","volume":"89","author":[{"given":"Yudai","family":"Fujimoto","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Horiuchi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Mitsui Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Murai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Matsukawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Fukuoka Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saitama Medical Center, Saitama Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Matsue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: A policy statement from the American Heart Association. <i>Circ Heart Fail<\/i> 2013; 6: 606\u2013619, doi:10.1161\/HHF.0b013e318291329a.","DOI":"10.1161\/HHF.0b013e318291329a"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Shiraishi Y, Kohsaka S, Sato N, Takano T, Kitai T, Yoshikawa T, et al. 9-Year trend in the management of acute heart failure in Japan: A report from the National Consortium of Acute Heart Failure Registries. <i>J Am Heart Assoc<\/i> 2018; 7: e008687, doi:10.1161\/JAHA.118.008687.","DOI":"10.1161\/JAHA.118.008687"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Kanaoka K, Iwanaga Y, Sumita Y, Nakai M, Miyamoto Y. Management and outcomes of acute heart failure hospitalizations in Japan. <i>Circ J<\/i> 2024; 88: 1265\u20131273, doi:10.1253\/circj.CJ-23-0350.","DOI":"10.1253\/circj.CJ-23-0350"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Sato Y, Yoshihisa A, Ide T, Tohyama T, Enzan N, Matsushima S, et al. Regional variation in the clinical practice and prognosis in patients with heart failure with reduced ejection fraction in Japan: A report from the Japanese Registry of Acute Decompensated Heart Failure (JROADHF). <i>Circ J<\/i> 2023; 87: 1380\u20131391, doi:10.1253\/circj.CJ-22-0774.","DOI":"10.1253\/circj.CJ-22-0774"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Yamashita M, Matsuzawa R, Kondo H, Kanata Y, Sakamoto R, Tamaki A. Heart failure management capability and exacerbation of heart failure: A 6-month prospective cohort study. <i>Circ Rep<\/i> 2023; 5: 245\u2013251, doi:10.1253\/circrep.CR-23-0042.","DOI":"10.1253\/circrep.CR-23-0042"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Heidenreich P. Heart failure management guidelines: New recommendations and implementation. <i>J Cardiol<\/i> 2024; 83: 67\u201373, doi:10.1016\/j.jjcc.2023.10.009.","DOI":"10.1016\/j.jjcc.2023.10.009"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Ohata T, Niimi N, Shiraishi Y, Nakatsu F, Umemura I, Kohno T, et al. Initiation and up-titration of guideline-based medications in hospitalized acute heart failure patients: A report from the West Tokyo Heart Failure Registry. <i>Circ J<\/i> 2023; 88: 22\u201330, doi:10.1253\/circj.CJ-23-0356.","DOI":"10.1253\/circj.CJ-23-0356"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Umemura I, Eguchi S, Morita Y, Mitani H, Iekushi K, Kato T. Relationship between left ventricular ejection fraction and treatment characteristics in hospitalized patients with heart failure: A Japanese database analysis. <i>Circ Rep<\/i> 2023; 5: 392\u2013402, doi:10.1253\/circrep.CR-23-0066.","DOI":"10.1253\/circrep.CR-23-0066"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Authors\/Task Force Members; McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. <i>Eur J Heart Fail<\/i> 2022; 24: 4\u2013131, doi:10.1002\/ejhf.2333.","DOI":"10.1002\/ejhf.2333"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Tsutsui H, Ide T, Ito H, Kihara Y, Kinugawa K, Kinugawa S, et al. JCS\/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure. <i>Circ J<\/i> 2021; 85: 2252\u20132291, doi:10.1253\/circj.CJ-21-0431.","DOI":"10.1253\/circj.CJ-21-0431"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial. <i>Lancet<\/i> 2022; 400: 1938\u20131952, doi:10.1016\/S0140-6736(22)02076-1.","DOI":"10.1016\/S0140-6736(22)02076-1"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Malgie J, Wilde MI, Clephas PRD, Emans ME, Koudstaal S, Schaap J, et al. Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study. <i>Eur J Heart Fail<\/i> 2024; 26: 1549\u20131560, doi:10.1002\/ejhf.3267.","DOI":"10.1002\/ejhf.3267"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Savarese G, Kishi T, Vardeny O, Adamsson Eryd S, Bodeg\u00e5rd J, Lund LH, et al. Heart failure drug treatment\u2013inertia, titration, and discontinuation: A multinational observational study (EVOLUTION HF). <i>JACC Heart Fail<\/i> 2023; 11: 1\u201314, doi:10.1016\/j.jchf.2022.08.009.","DOI":"10.1016\/j.jchf.2022.08.009"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Teng TK, Tromp J, Tay WT, Anand I, Ouwerkerk W, Chopra V, et al. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: A cohort study. <i>Lancet Glob Health<\/i> 2018; 6: e1008\u2013e1018, doi:10.1016\/S2214-109X(18)30306-1.","DOI":"10.1016\/S2214-109X(18)30306-1"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Ichihara YK, Kohsaka S, Kisanuki M, Sandhu ATS, Kawana M. Implementation of evidence-based heart failure management: Regional variations between Japan and the USA. <i>J Cardiol<\/i> 2024; 83: 74\u201383, doi:10.1016\/j.jjcc.2023.07.019.","DOI":"10.1016\/j.jjcc.2023.07.019"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Sueta D, Araki S, Usuku H, Fujisaki T, Kiyama T, Ishii M, et al. Clinical outcomes of patients from older community hospitalized for heart failure in guideline-directed medical therapy era: Insights from the COMPASS-HF registry. <i>J Cardiol<\/i> 2025; 85: 257\u2013259, doi:10.1016\/j.jjcc.2024.09.006.","DOI":"10.1016\/j.jjcc.2024.09.006"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Shoji S, Kaltenbach L, Granger BB, Fonarow GC, Al-Khalidi HR, Albert NM, et al. Guideline-directed medical therapy after hospitalization for acute heart failure: Insights from the CONNECT-HF. <i>J Am Heart Assoc<\/i> 2024; 13: e036998, doi:10.1161\/JAHA.124.036998.","DOI":"10.1161\/JAHA.124.036998"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Greene SJ, Mentz RJ, Felker GM. Outpatient worsening heart failure as a target for therapy: A review. <i>JAMA Cardiol<\/i> 2018; 3: 252\u2013259, doi:10.1001\/jamacardio.2017.5250.","DOI":"10.1001\/jamacardio.2017.5250"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Docherty KF, Jhund PS, Anand I, Bengtsson O, B\u00f6hm M, de Boer RA, et al. Effect of dapagliflozin on outpatient worsening of patients with heart failure and reduced ejection fraction: A prespecified analysis of DAPA-HF. <i>Circulation<\/i> 2020; 142: 1623\u20131632, doi:10.1161\/CIRCULATIONAHA.120.047480.","DOI":"10.1161\/CIRCULATIONAHA.120.047480"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Madelaire C, Gustafsson F, Stevenson LW, Kristensen SL, K\u00f8ber L, Andersen J, et al. One-year mortality after intensification of outpatient diuretic therapy. <i>J Am Heart Assoc<\/i> 2020; 9: e016010, doi:10.1161\/JAHA.119.016010.","DOI":"10.1161\/JAHA.119.016010"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Okumura N, Jhund PS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, et al. Importance of clinical worsening of heart failure treated in the outpatient setting: Evidence from the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF). <i>Circulation<\/i> 2016; 133: 2254\u20132262, doi:10.1161\/CIRCULATIONAHA.115.020729.","DOI":"10.1161\/CIRCULATIONAHA.115.020729"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Greene SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, Lam CSP, Lund LH, et al. Worsening heart failure: Nomenclature, epidemiology, and future directions: JACC review topic of the week. <i>J Am Coll Cardiol<\/i> 2023; 81: 413\u2013424, doi:10.1016\/j.jacc.2022.11.023.","DOI":"10.1016\/j.jacc.2022.11.023"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. <i>Circulation<\/i> 1993; 88: 107\u2013115, doi:10.1161\/01.cir.88.1.107.","DOI":"10.1161\/01.CIR.88.1.107"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Fiuzat M, Hamo CE, Butler J, Abraham WT, DeFilippis EM, Fonarow GC, et al. Optimal background pharmacological therapy for heart failure patients in clinical trials: JACC review topic of the week. <i>J Am Coll Cardiol<\/i> 2022; 79: 504\u2013510, doi:10.1016\/j.jacc.2021.11.033.","DOI":"10.1016\/j.jacc.2021.11.033"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Matsukawa R, Okahara A, Tokutome M, Itonaga J, Koga E, Hara A, et al. A scoring evaluation for the practical introduction of guideline-directed medical therapy in heart failure patients. <i>ESC Heart Fail<\/i> 2023; 10: 3352\u20133363, doi:10.1002\/ehf2.14524.","DOI":"10.1002\/ehf2.14524"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Matsukawa R, Kabu K, Koga E, Hara A, Kisanuki H, Sada M, et al. Optimizing guideline-directed medical therapy during hospitalization improves prognosis in patients with worsening heart failure requiring readmissions. <i>Circ J<\/i> 2024; 88: 1416\u20131424, doi:10.1253\/circj.CJ-24-0265.","DOI":"10.1253\/circj.CJ-24-0265"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, et al. JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure: Digest version. <i>Circ J<\/i> 2019; 83: 2084\u20132184, doi:10.1253\/circj.CJ-19-0342.","DOI":"10.1253\/circj.CJ-19-0342"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. <i>N Engl J Med<\/i> 2019; 381: 1995\u20132008, doi:10.1056\/NEJMoa1911303.","DOI":"10.1056\/NEJMoa1911303"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. <i>N Engl J Med<\/i> 2020; 383: 1413\u20131424, doi:10.1056\/NEJMoa2022190.","DOI":"10.1056\/NEJMoa2022190"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure. <i>N Engl J Med<\/i> 2014; 371: 993\u20131004, doi:10.1056\/NEJMoa1409077.","DOI":"10.1056\/NEJMoa1409077"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Spinar J, Jarkovsky J, Spinarova L, Mebazaa A, Gayat E, Vitovec J, et al. AHEAD score: Long-term risk classification in acute heart failure. <i>Int J Cardiol<\/i> 2016; 202: 21\u201326, doi:10.1016\/j.ijcard.2015.08.187.","DOI":"10.1016\/j.ijcard.2015.08.187"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Chen YJ, Sung SH, Cheng HM, Huang WM, Wu CL, Huang CJ, et al. Performance of AHEAD score in an Asian cohort of acute heart failure with either preserved or reduced left ventricular systolic function. <i>J Am Heart Assoc<\/i> 2017; 6: e004297, doi:10.1161\/JAHA.116.004297.","DOI":"10.1161\/JAHA.116.004297"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Brunner-La Rocca HP, Linssen GC, Smeele FJ, van Drimmelen AA, Schaafsma HJ, Westendorp PH, et al. Contemporary drug treatment of chronic heart failure with reduced ejection fraction: The CHECK-HF registry. <i>JACC Heart Fail<\/i> 2019; 7: 13\u201321, doi:10.1016\/j.jchf.2018.10.010.","DOI":"10.1016\/j.jchf.2018.10.010"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Greene SJ, Butler J, Albert NM, DeVore AD, Sharma PP, Duffy CI, et al. Medical therapy for heart failure with reduced ejection fraction: The CHAMP-HF registry. <i>J Am Coll Cardiol<\/i> 2018; 72: 351\u2013366, doi:10.1016\/j.jacc.2018.04.070.","DOI":"10.1016\/j.jacc.2018.04.070"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Skali H, Dwyer EM, Goldstein R, Haigney M, Krone R, Kukin M, et al. Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT. <i>Eur J Heart Fail<\/i> 2014; 16: 560\u2013565, doi:10.1002\/ejhf.71.","DOI":"10.1002\/ejhf.71"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Khan MS, Greene SJ, Hellkamp AS, DeVore AD, Shen X, Albert NM, et al. Diuretic changes, health care resource utilization, and clinical outcomes for heart failure with reduced ejection fraction: From the change the management of patients with heart failure registry. <i>Circ Heart Fail<\/i> 2021; 14: e008351, doi:10.1161\/CIRCHEARTFAILURE.121.008351.","DOI":"10.1161\/CIRCHEARTFAILURE.121.008351"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/7\/89_CJ-24-1020\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T03:16:00Z","timestamp":1751080560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/7\/89_CJ-24-1020\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-24-1020","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"CJ-24-1020"}}